The 2024 Impact Report of the Cancer Research Institute
August 10, 2024
August 10, 2024
NEW YORK, Aug. 10 (TNSres) -- Cancer Research Institute issued the following news:
Since our founding in 1953, the Cancer Research Institute (CRI) has been at the forefront of advancing immunotherapy, fundamentally reshaping cancer treatment, and establishing immunotherapy as the fourth pillar of cancer care.
Thanks to CRI's 71 years of dedication, 45 percent of all newly diagnosed cancer patients are eligible for at least one form of immunotherapy today.
. . .
Since our founding in 1953, the Cancer Research Institute (CRI) has been at the forefront of advancing immunotherapy, fundamentally reshaping cancer treatment, and establishing immunotherapy as the fourth pillar of cancer care.
Thanks to CRI's 71 years of dedication, 45 percent of all newly diagnosed cancer patients are eligible for at least one form of immunotherapy today.
. . .